Evidence map›Paper›PMID 35123442›Full record

ArticleBMC pregnancy and childbirth2022

The clinical evaluation of IIA balloon occlusion in caesarean delivery for patients with PAS: a retrospective study.

Ling Hong, Aner Chen, Jinliang Chen, Xiuxiu Li, Wenming Zhuang, Yijing Shen, Qiaohong Dai, Li Zhang

Open access · goldAbstract read
In one paragraph

Article in BMC pregnancy and childbirth, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Prophylactic internal iliac artery balloon occlusion in the management of placenta accreta spectrum disorders: a meta-analysis.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2025
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ling Hong *Department of obstetrics and gynecology, Ningbo women and children's hospital, Ningbo, China.
Aner Chen *Department of obstetrics and gynecology, Ningbo women and children's hospital, Ningbo, China.
Jinliang ChenRadiology department, Ningbo women and children's hospital, Ningbo, China.
Xiuxiu LiDepartment of science and education, Ningbo women and children's hospital, 339 liuting street, Ningbo city, Zhejiang province, China.
Wenming ZhuangDepartment of obstetrics and gynecology, Ningbo women and children's hospital, Ningbo, China.
Yijing ShenDepartment of science and education, Ningbo women and children's hospital, 339 liuting street, Ningbo city, Zhejiang province, China.
Qiaohong DaiDepartment of obstetrics and gynecology, Ningbo women and children's hospital, Ningbo, China.
Li ZhangDepartment of science and education, Ningbo women and children's hospital, 339 liuting street, Ningbo city, Zhejiang province, China. zhangli00501465@outlook.com.
Ningbo Medical Center Lihuili Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this study is the clinical evaluation of IIA balloon occlusion in the caesarean delivery in patients with a diagnosis of placenta accreta spectrum.

backgroundHigh incidence of cesarean section leads to the increasing incidence of placenta accreta spectrum (PAS), which contributes to serious consequences such as severe obstetric postpartum hemorrhage or even maternal mortality.

methodsFifty-eight patients with a diagnosis of PAS were retrospectively reviewed. The balloon group consisted of 23 patients, who underwent a caesarean delivery with internal iliac artery occlusion. 35 patients were in the control group, who had a standard caesarean delivery. The primary outcomes were estimated blood loss (EBL). The secondary outcomes were cesarean hysterectomy, blood transferring volume, operating time, intraoperative hemostatic approaches, surgical complications, balloon catheter-related complications, length of maternal stay, cost of hospitalization, and neonatal outcomes.

resultsNo difference was observed in estimated blood loss (EBL), blood transferring percentages and volume, additional measures to secure hemostasis, surgical complications, hospital stay postoperatively and newborn outcomes. More than 40% of the balloon group underwent hysterectomy because of uncontrollable postpartum bleeding (10 [43.48%] vs. 11 [31.43%], P=0.350). Complications related to occlusion of IIA did not occur. The duration of the surgery of the balloon group was significantly longer than that of the control group (123.52 min±74.76 versus 89.17±48.68, P=0.038), and the total hospitalization cost was also significantly higher than that of the control group (45116.67±9358.67 yuan versus 30615.41±11587.44 yuan, P=0.000).

conclusionIt does not permit to draw final conclusions for us on the effectiveness of the balloons IIA given the heterogeneity of selection of cases undergoing the procedures in the retrospective design. However, it is possible that IIA balloon occlusion may contribute to limiting intraoperative blood loss in more severe cases, particularly those undergoing peripartum hysterectomy.

Indexed as

AdultBalloon OcclusionBlood Loss, SurgicalCase-Control StudiesCesarean SectionCost of IllnessFemaleHumansHysterectomyIliac ArteryOperative TimePlacenta AccretaPostpartum HemorrhagePregnancyRetrospective StudiesIIA balloon occlusionPlacenta accreta spectrumPlacenta accrete

Identifiers

PMID35123442
PMCPMC8817511
OpenAlexW4210437381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.